Arrowstreet Capital
TBIO

Arrowstreet Capital’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Arrowstreet Capital’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-94,678
Closed -$1.7M – 2615
2020
Q2 		$1.7M Buy
+94,678
New +$1.43M ﹤0.01% 1549
2020
Q1 		– Sell
-11,600
Closed -$94K – 2221
2019
Q4 		$94K Buy
+11,600
New +$107K ﹤0.01% 1670

Other funds holding TBIO

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AVA
Atlas Venture Advisors Boston, Massachusetts $143M AUM 25.68% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Arrowstreet Capital's TBIO Position: Q3 2020 in Review

Arrowstreet Capital sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2020, closing a stake of 94,678 shares — an estimated $1.7M sold.

Arrowstreet Capital first reported a position in TBIO in Q4 2019 and held it in 2 quarters. The position peaked at $1.7M in Q2 2020. 132 funds tracked by Wall St. Rank hold TBIO as of Q3 2020.

  • Arrowstreet Capital reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Arrowstreet Capital sold 94,678 Translate Bio, Inc. Common Stock shares in Q3 2020, an estimated $1.7M.
  • Arrowstreet Capital first reported a position in Translate Bio, Inc. Common Stock in Q4 2019 and held it in 2 quarters.
  • Arrowstreet Capital's Translate Bio, Inc. Common Stock position peaked at $1.7M in Q2 2020.
  • 132 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2020.

Based on Arrowstreet Capital's 13F filing for Q3 2020, filed 12 Nov 2020.